Targeting reactive oxygen species (ROS) to combat the age-related loss of muscle mass and function.

Biogerontology · 2020 · PMC7347670 · PMID 32447556

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Thus, differences in dose and duration of treatment with SS-31 in these models may be significant factors in the observed differences in outcome.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.